EP0988024A1 - Traitement de la saumure - Google Patents

Traitement de la saumure

Info

Publication number
EP0988024A1
EP0988024A1 EP98918739A EP98918739A EP0988024A1 EP 0988024 A1 EP0988024 A1 EP 0988024A1 EP 98918739 A EP98918739 A EP 98918739A EP 98918739 A EP98918739 A EP 98918739A EP 0988024 A1 EP0988024 A1 EP 0988024A1
Authority
EP
European Patent Office
Prior art keywords
brine
additive
oil
surfactant
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98918739A
Other languages
German (de)
English (en)
Other versions
EP0988024A4 (fr
Inventor
Frederick Robert Sharp
James Richard Von Krosigk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0988024A1 publication Critical patent/EP0988024A1/fr
Publication of EP0988024A4 publication Critical patent/EP0988024A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]

Definitions

  • brine solutions are used for various applications and these can frequently result in damage, or at least, irritation to the skin of a user if skin contact occurs.
  • brine is used throughout the specification to refer to solutions of various types of salts, typically but not exclusively, solutions of calcium chloride, calcium bromide, zinc bromide, zinc chloride, formates and/ or acetates or blends or mixtures thereof, and including what are called “heavy brines" being “super-saturated” solutions.
  • brine When brine is in contact with human tissue, it is believed to attack that tissue in a number of ways. Firstly, brine may act as an acid initially, as a hydrogen donor, attacking the tissue by altering its pH. Secondly, the brine can act as an astringent and de-moisturiser with long exposure. Thirdly, in extreme cases, the brine can act as an emulsifier of the fats and oil in skin tissue to complexes which are removed with the brine when the exposed skin tissue is washed.
  • an object of the present invention to provide an additive for brine and/or a method of treating brine which will avoid or at least obviate the above problems in the use of brine, or which at least will provide the public with a useful choice.
  • a method of treating brine which will at least alleviate its effect on human skin tissue comprising adding to the brine an epidermically effective amount of a surfactant, polymer and/or oil.
  • the method as immediately above defined includes epidermically effective amounts of at least two of the said surfactant, polymer and/or oil.
  • the method includes epidermically effective amounts of a surfactant, polymer and oil.
  • a method as defined in the paragraph immediately above includes, by volume;
  • one or more surfactants approximately 83 % to approximately 84%
  • one or more polymers approximately 6% to 7%; the above percentages being based on the total active ingredients.
  • an additive for brine to alleviate the effect of brine (as herein defined) on human skin tissue comprises an epidermically effective amount of a surfactant, polymer and/or oil.
  • the additive as defined immediately above includes at least two of the said surfactant, polymer and/or oil.
  • the additive as defined in either of the two paragraphs immediately above includes a surfactant, polymer and oil
  • an additive as defined in the paragraph immediately above has by volume and based on the total volume of the active ingredients:
  • one or more surfactants approximately 83% to 84%;
  • one or more polymers approximately 6% to 7 % .
  • an additive for brine as defined in any one of the eleven immediately preceding paragraphs is in the form of a cream, lotion, spray, liquid, cleanser or the like.
  • brines are used in various strengths, depending on the uses to which they will be put.
  • the brines will typically have an adverse effect on any human skin tissue with which they come into contact, which effect can range from merely skin irritation, erythema, producing redness, through to edema where the skin is ulcerated and swollen.
  • erythema producing redness
  • edema where the skin is ulcerated and swollen.
  • degrees of effect as well, so that a brine can produce severe erythema with beet redness and with eschar formation, or with severe edema producing swelling which can be more than 1 mm and can extend well beyond the initial area of exposure.
  • the present invention provides in one embodiment an additive which when applied to human skin tissue, is able to prevent or at least alleviate damage to human skin tissue with which it comes into contact.
  • the term "epidermically effective" as used throughout this specification has this meaning.
  • the additive of the present invention is believed to buffer 0 the brine insofar as it reduces or eliminates the pH effect on the skin, provides the skin with a moisturiser or at least prevents or limits the effect of the brine until it is able to be removed.
  • the additive of the present invention may be added ⁇ • ⁇ directly to the brine to protect against accidental or work-related exposure to the brine. Additionally or alternatively, the additive of the present invention, may it is envisaged, be used as a barrier, cream or lotion for workers to apply to their skin which would increase their protection when the additive may already have been used in the brine itself. Such cream or lotion may be - u recommended for workers who may be overly sensitive to the effect of brine. Additionally, such a cream or lotion or other liquid could, it is envisaged, be used to protect the outerwear of workers, particularly leather wearing apparel which is subject to severe attack by brine.
  • the additive of the present invention could be provided in a spray form which could be in individual containers for use by workers or perhaps could be used as a body spray in a shower unit.
  • the additive of the present invention could be used in a cleanser used for cleaning any skins which may have been exposed to brine.
  • brines may have substantially different formulations and be of substantially different strengths
  • the additive of the present invention may have a specific formulation which may be specifically adapted for use with a particular brine.
  • the additive is required to have high water solubility so that even in a super-saturated heavy brine, the additive may be accepted.
  • Glycoaminoglycans (and Hydrolised); Saiclic acid and derivatives; Cucumber extract; and Witch Hazel extract.
  • ingredients may have some action in more than one category, e.g. some of the polymers will also be surfactants and some of the oils may be polymeric in nature.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur un additif incorporé à la saumure, et/ou sur un procédé de traitement de la saumure de façon à protéger les tissus cutanés lorsqu'ils sont en contact avec la saumure. L'invention porte également sur l'utilisation d'une quantité efficace pour l'épiderme d'un tensioactif, d'un polymère et/ou d'une huile. Les huiles, polymères et tensioactifs appropriés sont ceux énumérés dans la demande.
EP98918739A 1997-04-30 1998-04-28 Traitement de la saumure Withdrawn EP0988024A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9708820.7A GB9708820D0 (en) 1997-04-30 1997-04-30 Improvements in and relating to brine
GB9708820 1997-04-30
PCT/US1998/008356 WO1998048777A1 (fr) 1997-04-30 1998-04-28 Traitement de la saumure

Publications (2)

Publication Number Publication Date
EP0988024A1 true EP0988024A1 (fr) 2000-03-29
EP0988024A4 EP0988024A4 (fr) 2000-07-26

Family

ID=10811624

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98918739A Withdrawn EP0988024A4 (fr) 1997-04-30 1998-04-28 Traitement de la saumure

Country Status (6)

Country Link
EP (1) EP0988024A4 (fr)
AU (1) AU727844B2 (fr)
CA (1) CA2288193A1 (fr)
GB (1) GB9708820D0 (fr)
NO (1) NO995295L (fr)
WO (1) WO1998048777A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1167681A (fr) * 1955-12-30 1958-11-27 Fettchemie Produits formant film protecteur de la peau contre des solutions aqueuses
EP0351766A2 (fr) * 1988-07-19 1990-01-24 Vogt-Dembowski, Elisabeth, Dr. med. Préparation dermatologique
US5208013A (en) * 1991-06-03 1993-05-04 Olympus International, Inc. Composition for skin care and protection
EP0834306A2 (fr) * 1996-10-07 1998-04-08 LA ROCHE POSAY Laboratoire Pharmaceutique Emulsion cosmétique E/H à forte teneur en électrolytes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374734A (en) * 1981-06-19 1983-02-22 Cities Service Co. Emulsion breaking of surfactant stabilized crude oil in water emulsions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1167681A (fr) * 1955-12-30 1958-11-27 Fettchemie Produits formant film protecteur de la peau contre des solutions aqueuses
EP0351766A2 (fr) * 1988-07-19 1990-01-24 Vogt-Dembowski, Elisabeth, Dr. med. Préparation dermatologique
US5208013A (en) * 1991-06-03 1993-05-04 Olympus International, Inc. Composition for skin care and protection
EP0834306A2 (fr) * 1996-10-07 1998-04-08 LA ROCHE POSAY Laboratoire Pharmaceutique Emulsion cosmétique E/H à forte teneur en électrolytes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9848777A1 *

Also Published As

Publication number Publication date
CA2288193A1 (fr) 1998-11-05
NO995295L (no) 1999-12-29
GB9708820D0 (en) 1997-06-25
WO1998048777A1 (fr) 1998-11-05
AU7160898A (en) 1998-11-24
NO995295D0 (no) 1999-10-29
AU727844B2 (en) 2001-01-04
EP0988024A4 (fr) 2000-07-26

Similar Documents

Publication Publication Date Title
JP4133837B2 (ja) 皮膚保湿用ゲルおよび方法
EP0715852B1 (fr) Utilisation de l'acide hyaluronique ou son sel pour le traitement des désordres de la peau
DK1888024T4 (en) Topical compositions
CN111110577A (zh) 一种温和型除螨止痒沐浴露及其制备方法
JP2002053428A (ja) 皮膚外用剤
EP3769750A1 (fr) Composition d'acide hyaluronique pour usage externe sur la peau et son utilisation
KR20200131850A (ko) 국소 피부 관리 조성물
JPH0774157B2 (ja) 皮膚疾患治療薬
JP2003128531A (ja) 皮膚外用剤
WO2018118448A1 (fr) Compositions contenant de l'acide hyaluronique et des actifs anti-hyaluronidase synergiques
JP7430372B2 (ja) パック剤
AU727844B2 (en) Brine treatment
JP2001172167A (ja) 洗浄剤組成物
EP1467702B1 (fr) Composition de soin de cicatrices
JP3479048B2 (ja) 化粧料及び不織布含浸化粧料
JP2005060233A (ja) 皮膚外用剤
JP2005519935A (ja) 皮膚薬用化粧品の送達用の組成物および方法
CN105662911A (zh) 一种含骨胶原的眼部走珠精华露
WO2021077320A1 (fr) Composition pour le soin de la peau
MXPA99011075A (es) Tratamiento de salmuera
JP3240553B2 (ja) 薬草クリーム及び薬草クリーム用調製液
KR100451388B1 (ko) 발관리 전용 화장료 조성물
WO2018229084A1 (fr) Composition pour le traitement de la blépharite
JP2002226352A (ja) 皮膚外用剤
RU2780260C1 (ru) Средство косметического использования для кожи

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE DK ES FR GB IE IT NL

A4 Supplementary search report drawn up and despatched

Effective date: 20000615

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE DK ES FR GB IE IT NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 7/48 A, 7A 61K 7/40 B

17Q First examination report despatched

Effective date: 20020409

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020820